US PTAB IP Litigation

Cortex MCP seeks Director Review of the PTAB’s Final Written Decision that cancelled 29 claims of its token‑payment patent. The owner contends the Board invented a new obviousness theory not raised in Visa’s petitions, violating procedural rules.

TESLA, INC. v.iQar Inc.

· IPR2024-00499

Tesla, Inc. has filed a Petition challenging 17 claims of iQar Inc.'s patent (US 10,829,002) in the PTAB. The challenge asserts that the claims are obvious over various combinations of prior art references, including Kudo-325 and Kudo-066.

Visa, Inc. v.Cortex MCP, Inc.

· IPR2024-00487

Visa challenges Cortex MCP's '531 patent in an IPR, arguing that all 13 asserted claims are obvious over various combinations of prior art. The petitioner relies heavily on references like Oborne, Purves, and Stafford to demonstrate the lack of inventive step in digital credential management systems.

Visa, Inc. v.Cortex MCP, Inc.

Visa challenges Cortex MCP's patent (9251531) in an IPR, arguing that the credential management technology is obvious over prior art. The petitioner asserts that existing methods for tokenization and verifiable electronic credentials render the claims unpatentable.

patent instituted · Jan 25, 2024

JACS Solutions, Inc. v.Global Tel*Link Corporation d/b/a ViaPath Technologies

· IPR2024-00484

JACS Solutions challenges Global Tel*Link's '9030292 Patent, asserting that 29 claims are obvious under 35 U.S.C. § 103. The petitioner argues that the claimed features of secure facility monitoring systems are predictable combinations of existing prior art in telecommunications and security technology.

TESLA, INC. v.iQar Inc.

· IPR2024-00499

Tesla successfully secured the institution of Inter Partes Review against iQar Inc.'s patent 10,829,002, challenging claims related to vehicle destination prediction and power management.

patent instituted · Jan 25, 2024

Visa, Inc. v.Cortex MCP, Inc.

· IPR2024-00487

Visa, Inc.'s IPR petition against Cortex MCP, Inc.'s patent was instituted by the PTAB, allowing the case to proceed to trial. The Board adopted key claim constructions, including defining 'OVER file' to encompass tokens and NFC interactions for 'scan,' confirming sufficient basis for unpatentability arguments.

patent instituted · Jan 25, 2024

Visa, Inc. v.Cortex MCP, Inc.

patent all challenged claims upheld · Jan 25, 2024

Visa, Inc., successfully petitioned for institution in a high-stakes IPR against Cortex MCP, Inc.'s digital credentialing patent (9251531). The Board adopted key claim constructions favorable to the Petitioner and found sufficient evidence of obviousness based on prior art references.

Visa, Inc. v.Cortex MCP, Inc.

patent final · Jan 25, 2024

Visa's claims against Cortex MCP were upheld by the PTAB Director in a review of the Final Written Decision. The Board confirmed that Oborne discloses the token verification limitation central to Visa's patent.

TESLA, INC. v.iQar Inc.

· IPR2024-00499

The Board found all challenged claims unpatentable over combinations of Kudo-325 and Kudo-066. The petitioner successfully argued that the prior art combination teaches or suggests the necessary elements for destination prediction and power management in vehicles. This final decision affirms the obviousness rejection against iQar Inc.'s patent.

patent Final Written Decision · Jan 25, 2024

Visa, Inc. v.Cortex MCP, Inc.

The Board found that the majority of claims (24 out of 33) were unpatentable over various combinations of prior art references. The key finding was that Oborne teaches core tokenization elements, while other combinations failed to provide sufficient motivation for the claimed improvements.

patent · Jan 24, 2024

Dr. Reddy's Laboratories S.A. et al. v.Eye Therapies, LLC et al.

Dr. Reddy’s labs and Eye Therapies have jointly filed a motion to keep their settlement agreement confidential and separate from the IPR docket. The request cites statutory authority and seeks limited disclosure.

Motorola Solutions, Inc. v.STA Group, LLC

Motorola Solutions and STA Group settled their dispute over Patent 8,145,249, filing a joint motion that led the PTAB to terminate the inter partes review.

patent · Jan 24, 2024

Motorola Solutions, Inc. v.STA Group, LLC

Motorola Solutions and STA Group filed a joint motion asking the PTAB to keep their settlement agreement confidential under 35 U.S.C. § 317(b). They contend the agreement contains highly sensitive business information that could be harmed if disclosed.

Motorola Solutions, Inc. v.STA Group, LLC

Motorola Solutions and STA Group have settled their dispute over a VoIP audio‑mixing patent and jointly moved to terminate the pending inter partes review.

Dr. Reddy's Laboratories S.A. et al. v.Eye Therapies, LLC et al.

Dr. Reddy’s Laboratories and Eye Therapies have settled their dispute over U.S. Patent No. 11,833,245 and jointly filed a motion to terminate the inter partes review. The Board is asked to end the proceeding under 35 U.S.C. § 317, citing policy and precedent favoring termination after settlement.

Dr. Reddy's Laboratories S.A. et al. v.Eye Therapies, LLC et al.

patent null · Jan 24, 2024

Dr. Reddy’s Laboratories and Eye Therapies entered a settlement that led to the joint termination of two inter partes review proceedings covering patents 11,833,245 and 11,596,600. The Board granted the termination and kept the settlement agreement confidential.

patent · Jan 24, 2024

LUMI LEGEND CORPORATION v.Manehu Product Alliance, LLC

· PGR2024-00014

Lumi Legend has filed a PGR petition seeking cancellation of claims 33‑36 of U.S. Patent 11,781,703, alleging lack of written description, indefiniteness, anticipation, and obviousness. The petition relies on prior art such as Clary, Juan, Pankros, Tsuji, and Xu. It also argues the patent is eligible for PGR and urges the Board not to deny institution.

Dr. Reddy's Laboratories S.A. et al. v.Eye Therapies, LLC et al.

patent null · Jan 24, 2024

Dr. Reddy's Laboratories challenges Eye Therapies' patent (11833245) in an IPR, arguing all claims are obvious over prior art including Gil and Norden. The petition asserts that the combination of known elements for treating eye redness is motivated by POSA knowledge, favoring institution under Hatch-Waxman principles.

Motorola Solutions, Inc. v.STA Group, LLC

patent instituted · Jan 24, 2024

Motorola Solutions challenges STA Group's 8145249 patent, arguing that its core technology for mixing disparate communication streams is obvious over prior art. The petition asserts multiple grounds of obviousness (35 U.S.C. § 103) using references like Botha and combinations involving Radenkovic and McDonald.

LUMI LEGEND CORPORATION v.Manehu Product Alliance, LLC

· PGR2024-00014

LUMI LEGEND CORPORATION successfully petitioned for institution of its PGR against Manehu Product Alliance regarding television mounting systems. The Board found that the petitioner met the likelihood standard by asserting claims 33-36 are likely unpatentable over a combination of Clary and Tsuji, despite patent owner arguments about mechanical interference.

patent instituted · Jan 24, 2024

Dr. Reddy's Laboratories S.A. et al. v.Eye Therapies, LLC et al.

patent instituted · Jan 24, 2024

Dr. Reddy's Laboratories successfully secured institution status for an IPR against Eye Therapies, LLC regarding ophthalmic formulations. The Board found a reasonable likelihood of prevailing on obviousness (35 U.S.C. § 103) based on the combination of prior art references.

Motorola Solutions, Inc. v.STA Group, LLC